Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Class C G protein-coupled receptors (GPCRs) represent a distinct family of cell surface receptors characterized by a large extracellular N-terminal domain, often referred to as the Venus flytrap domain, which facilitates the binding of diverse ligands including amino acids, ions, and small molecules (IUPHAR/BPS Guide to Pharmacology). This family includes several physiologically vital targets such as the metabotropic glutamate receptors (mGluRs), GABA-B receptors, the calcium-sensing receptor (CASR), and taste receptors (T1Rs), all of which are essential for mediating neurotransmission and maintaining systemic ion balance (UniProt). The CASR, for instance, is a critical regulator of calcium homeostasis, sensing minute changes in extracellular calcium to modulate parathyroid hormone secretion (StatPearls). Dysregulation of Class C GPCRs is linked to a wide range of conditions, including secondary hyperparathyroidism, chronic kidney disease, schizophrenia, and neurological disorders like Fragile X syndrome (PubMed). Pharmacological targeting of these receptors often utilizes allosteric modulators, such as the calcimimetic cinacalcet, which provide a more nuanced control of receptor activity compared to traditional agonists or antagonists (DrugBank).
Allosteric modulation (positive and negative), agonism, and antagonism of receptor signaling activity.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Class C G protein-coupled receptor (Class C GPCR).